Cochlear

Cochlear Gross Profit/Assets

The Gross Profit to Assets Ratio of Cochlear (COH.AX) as of Nov 13, 2026 is 63.26 %. In the previous year, Gross Profit to Assets Ratio was 61.16 % — a change of 3.43% (higher).

Gross Profit/Assets

63.26 %

YoY

3.43%

Last updated:

Gross Profit to Assets Ratio of Cochlear is 2026 63.26 % . Gross Profit to Assets Ratio of Cochlear was 2025 61.16 % . It decreases by 3.43% higher compared to the previous year.

The Cochlear Gross Profit/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit/Assets
Date
Gross Profit/Assets
Jan 1, 2019
77.99 AUD
Jan 1, 2020
39.02 AUD
Jan 1, 2021
44.64 AUD
Jan 1, 2022
49.90 AUD
Jan 1, 2023
57.14 AUD
Jan 1, 2024
60.96 AUD
Jan 1, 2025
61.16 AUD
Jan 1, 2026
63.26 AUD
The Cochlear Gross Profit/Assets history
YEARGross Profit/AssetsYoY
63.26 %+3.43%
61.16 %+0.33%
60.96 %+6.69%
57.14 %+14.50%
49.90 %+11.78%
44.64 %+14.42%
39.02 %-49.97%
77.99 %-10.00%
86.65 %+9.97%
78.80 %-5.34%
83.25 %+12.06%
74.29 %+5.30%
70.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Gross Profit to Assets Ratio of Cochlear is 63.26 % in 2026.

Gross Profit to Assets Ratio of Cochlear changed from 61.16 % to 63.26 %, representing a 3.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit to Assets Ratio Cochlear since 2006 – with annual values, charts, and detailed analysis.

Gross Profit/Assets measures how efficiently a company uses its assets to generate gross profit. Research shows it is a strong predictor of future stock returns.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Profit to Assets Ratio's Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Profit to Assets Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Profit to Assets Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cochlear

All Key Metrics — Cochlear